Kantarjian, Hagop M. http://orcid.org/0000-0002-1908-3307
Article History
Received: 30 August 2023
Revised: 5 September 2023
Accepted: 26 September 2023
First Online: 5 October 2023
Change Date: 10 October 2023
Change Type: Update
Change Details: The supertitle has been corrected.
Competing interests
: HMK reports research grants and honoraria from AbbVie, Amgen, Amphista, Ascentage, Astellas, Biologix, Curis, Daiichi-Sankyo, Immunogen, Ipsen Biopharmaceuticals, Jazz, KAHR Medical, Labcorp, Novartis, Pfizer, Shenzhen Target Rx, Stemline, Takeda.